Bhat Laxminarayan has filed 8 insider transactions across 1 company since April 2023.
Most recent transaction: a grant/award of 40925 shares of REVIVA PHARMACEUTICALS HOLDINGS, INC. ($RVPH) on March 18, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 40925 | $0.00 | 150,075.0000 | 115,058,619 | 37.49% | 0.04% |
| March 18, 2026 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 109150 | $0.00 | 150,075.0000 | 115,058,619 | 266.71% | 0.09% |
| Feb. 13, 2025 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 519000 | $0.00 | 700,500.0000 | 0 | 285.95% | 0.00% |
| Feb. 13, 2025 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 181500 | $0.00 | 700,500.0000 | 0 | 34.97% | 0.00% |
| Sept. 15, 2024 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 77843 | $0.00 | 236,294.0000 | 0 | 49.13% | 0.00% |
| Sept. 15, 2024 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 158451 | $0.00 | 236,294.0000 | 0 | 203.55% | 0.00% |
| April 25, 2023 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 443000 | $0.00 | 593,000.0000 | 0 | 295.33% | 0.00% |
| April 25, 2023 | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $RVPH | Bhat Laxminarayan | President and CEO | A | Stock Option (right to buy) | 150000 | $0.00 | 593,000.0000 | 0 | 33.86% | 0.00% |